Seeking Alpha HealthcareOriginal article
Inogen outlines $355M-$361M 2026 revenue while targeting about $4M adjusted EBITDA amid U.S. channel mix pressure
EarningsNegative
AI Analysis
Summary
Inogen provided 2026 revenue guidance of $355M-$361M with targeted adjusted EBITDA of approximately $4M, citing U.S. channel mix pressure as a headwind.
Financial Highlights
Revenue
$355M-$361M
Guidance
2026 revenue guidance of $355M-$361M with approximately $4M adjusted EBITDA
Importance:3/10
Sentiment:
-0.30
guidancerevenueEBITDAchannel mix pressureU.S. market
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on August 7, 2026 2:25 PM
